Département de Pharmacologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4.
Biochem Pharmacol. 2010 Oct 1;80(7):990-9. doi: 10.1016/j.bcp.2010.06.004. Epub 2010 Jun 19.
We present a photoaffinity labeling study of the human Angiotensin II (AngII) type 1 receptor (hAT(1)) and a constitutively active mutant (CAM) N111G hAT(1) at multiple temperatures using a p-benzoyl-l-phenylalanine (Bpa) containing AngII analogue (125)I-[Sar(1), Bpa(8)] AngII and the Methionine Proximity Approach (MPA). By introducing Met residues, which react selectively with Bpa, by mutagenesis in hAT(1) and its CAM, we were able to identify the position of residues that surround the Bpa moiety in the receptor-ligand complexes. Here we refined this characterization by controlling and varying (from -20 to 50 degrees C) the temperature at which the photolabeling was carried out. The hAT(1) Met mutant, as well as CAM double mutant, photolabeled receptors were digested with CNBr and the fragmentation patterns were quantified by radioactive and densitometric analysis. Many important and significant changes in the fragmentation patterns were observed as function of both the temperature of photolysis and the context of constitutive activation. The ligand-receptor complex was increasingly flexible as temperature was increased, i.e. that the Bpa moiety could more easily label increasingly distant residues. These fragmentation patterns were converted into distance constraints that were included into a simulated annealing protocol in order to explore the extent of these conformational changes. In the context of constitutive activation, the 6th transmembrane domain (TM6) was found to exhibit a relative outward movement while TM2 and 5 were found to move closer to the ligand binding site. TM3 showed a slight displacement.
我们展示了一项光亲和标记研究,该研究针对人类血管紧张素 II(AngII)受体 1 型(hAT(1))和一个组成型激活突变体(CAM)N111G hAT(1),使用含有 p-苯甲酰基-l-苯丙氨酸(Bpa)的血管紧张素 II 类似物(125)I-[Sar(1),Bpa(8)]AngII 和甲硫氨酸接近法(MPA),在多个温度下进行。通过突变 hAT(1)及其 CAM 中的 Met 残基,引入可与 Bpa 选择性反应的残基,我们能够确定受体 - 配体复合物中围绕 Bpa 部分的残基位置。在这里,我们通过控制和改变(从-20 至 50°C)光标记进行的温度,进一步完善了这一特征。hAT(1)Met 突变体和 CAM 双突变体光标记的受体用 CNBr 消化,并通过放射性和密度计分析对碎片模式进行定量。随着光解温度和组成型激活背景的变化,观察到许多重要和显著的碎片模式变化。随着温度的升高,配体 - 受体复合物变得越来越灵活,即 Bpa 部分可以更容易地标记越来越远的残基。这些片段模式被转化为距离约束,这些约束被纳入模拟退火协议中,以探索这些构象变化的程度。在组成型激活的背景下,发现第 6 个跨膜域(TM6)表现出相对向外的运动,而 TM2 和 5 则发现更接近配体结合位点。TM3 显示出轻微的位移。